Anthrax suspect commits suicide

A biodefense researcher committed suicide this week, just as the US government was about to indict him for the 2001 anthrax attacks that killed five people and caused a national panic. The microbiologist, Bruce E. Ivins, whose death was first reported today (August 1) in the linkurl:Los Angeles Times,;http://www.latimes.com/news/nationworld/nation/la-na-anthrax1-2008aug01,0,2864223.story?page=1, was a top scientist at a US Army biodefense research facility in Fort Detrick, Md., where he worked

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A biodefense researcher committed suicide this week, just as the US government was about to indict him for the 2001 anthrax attacks that killed five people and caused a national panic. The microbiologist, Bruce E. Ivins, whose death was first reported today (August 1) in the linkurl:Los Angeles Times,;http://www.latimes.com/news/nationworld/nation/la-na-anthrax1-2008aug01,0,2864223.story?page=1, was a top scientist at a US Army biodefense research facility in Fort Detrick, Md., where he worked on developing an anthrax vaccine. He was also closely involved in analyzing samples from the 2001 attacks. Ivins's suicide comes just a month after the US government paid out $5.8 million to settle a lawsuit brought by linkurl:Steven J. Hatfill,;http://www.the-scientist.com/blog/display/54807/ a biodefense researcher and colleague of Ivins and long the unofficial primary suspect in the case despite the absence of clear evidence. According to the Times, Army officials had questioned Ivins in 2001 because he had failed to report anthrax contaminations found in his office between December 2001 and April 2002. Ivins claimed that the contamination resulted from a lab technician's accidental spills, and he was not disciplined for keeping the spills secret. Investigators began to focus their suspicions on Ivins after a new team of investigators took charge of the anthrax case in late 2006, and began reexamining old leads. "He buckled under government pressure," Ivins's brother told the Times. He had not been publically named as a suspect in the case, however. According to the linkurl:Associated Press;http://www.nytimes.com/aponline/us/AP-Anthrax-Scientist.html?ref=us&pagewanted=print, the FBI was investigating whether Ivins had released the anthrax in order to test a vaccine he had developed. Government officials are expected to announce in the next several days whether his death will mean the close the investigation, or whether they believe Ivins acted with others, the AP reports.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Alla Katsnelson

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide